{"success":true,"data":{"pressRelease":{"id":"169731","rtpr_id":"nPreGyNBYa-20261015","ticker":"YSG","exchange":"NYSE","all_tickers":["YSG"],"title":"Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics Congress with Record 20 Research Presentations","author":"PR Newswire","published_at":"2026-10-15T05:47:10.650Z","article_body":"Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics\nCongress with Record 20 Research Presentations\nPR Newswire\n\nGUANGZHOU, China, Oct. 15, 2026\n\nGUANGZHOU, China, Oct. 15, 2026 /PRNewswire/ -- Yatsen Holding Limited (NYSE:\nYSG) (Yatsen Group), a leading China-based beauty group, presented a record 20\nresearch submissions at the 36th IFSCC Congress in Perth — nearly double its\n2025 total and marking its fifth consecutive year at the world's leading\nconference for cosmetics science. Yatsen's 20 studies were selected from more\nthan 1,200 submissions following three rounds of expert review, underscoring\nits sustained investment in scientific innovation and its leading role in\nChina's cosmetics sector.\n\n\nBreakthroughs Across Nine Cutting-Edge Fields\n\n\"IFSCC is a leading science forum in cosmetic industry\" said Jing Cheng, Chief\nScientific Officer of Yatsen Group. \"Achieving a record 20 accepted\ncontributions across our core brands reflects the collaborative strength of\nour global R&D ecosystem. We remain committed to translating cutting-edge\nscience into high-efficacy beauty solutions for consumers worldwide.\"\n\nYatsen's featured research spanned nine cutting-edge fields, including\nadvanced scientific mechanisms, active ingredient innovation, efficacy\nevaluation, skin microbiome, color cosmetics innovation, skin neuroscience,\npreservative and microbiological science, computational toxicology, and\nformulation & delivery system innovation.\n\nAt the congress, Yatsen Group's R&D Director, Yi Deng, delivered a podium\npresentation on a novel microbiology testing methodology that minimizes\npreservative interference and reduces false negatives, establishing a quality\nassurance standard more reflective of real-world production across cosmetic\nformats.\n\n\nAdditionally, Yatsen's major brands —  DR.WU, Galénic, Eve Lom and Perfect\nDiary,  — presented technological applications spanning gentle skincare,\nanti-aging, eye-area care, clinical skin research and color cosmetics\ninnovation.\n\nSustained R&D Commitment\n\nYatsen's R&D network spans an advanced manufacturing hub, three global R&D\ncenters, six joint laboratories and more than 20 joint research platforms. The\nGroup has invested over RMB 770 million in R&D, with annual spending exceeding\n3% of revenue for four consecutive years. As of June 30, 2026, it filed 282\npatent applications and published 55 academic papers.\n\nAbout Yatsen Group\n\nYatsen Holding Limited (NYSE: YSG) (Yatsen Group) is a leading China-based\nbeauty group with the vision of becoming a world-class beauty innovation\npioneer. Founded in 2016, its brands — including Galénic, DR.WU (mainland\nChina business), Eve Lom, Perfect Diary and Little Ondine — cover consumer\nsegments from the mass market to prestige and clinical-grade skincare.\n\nMedia Contact: \n\nWebsite: www.yatsenglobal.com\nLinkedIn: www.linkedin.com/company/yatsen\nContact:public.affairs@yatsenglobal.com \n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/yatsen-group-expands-scientific-presence-at-prestigious-ifscc-cosmetics-congress-with-record-20-research-presentations-302909564.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2013986/20261014225821EDT_image_1.jpg?id=OA3020902\nhttps://mmx.prnewswire.com/media/MS2013984/20261014225821EDT_image_2.jpg?id=OA3020901\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPreGyNBYa-20261015","title":"Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics Congress with Record 20 Research Presentations","author":"PR Newswire","ticker":"YSG","created":"2026-10-15T05:47:10.650Z","tickers":["YSG"],"exchange":"NYSE","article_body":"Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics\nCongress with Record 20 Research Presentations\nPR Newswire\n\nGUANGZHOU, China, Oct. 15, 2026\n\nGUANGZHOU, China, Oct. 15, 2026 /PRNewswire/ -- Yatsen Holding Limited (NYSE:\nYSG) (Yatsen Group), a leading China-based beauty group, presented a record 20\nresearch submissions at the 36th IFSCC Congress in Perth — nearly double its\n2025 total and marking its fifth consecutive year at the world's leading\nconference for cosmetics science. Yatsen's 20 studies were selected from more\nthan 1,200 submissions following three rounds of expert review, underscoring\nits sustained investment in scientific innovation and its leading role in\nChina's cosmetics sector.\n\n\nBreakthroughs Across Nine Cutting-Edge Fields\n\n\"IFSCC is a leading science forum in cosmetic industry\" said Jing Cheng, Chief\nScientific Officer of Yatsen Group. \"Achieving a record 20 accepted\ncontributions across our core brands reflects the collaborative strength of\nour global R&D ecosystem. We remain committed to translating cutting-edge\nscience into high-efficacy beauty solutions for consumers worldwide.\"\n\nYatsen's featured research spanned nine cutting-edge fields, including\nadvanced scientific mechanisms, active ingredient innovation, efficacy\nevaluation, skin microbiome, color cosmetics innovation, skin neuroscience,\npreservative and microbiological science, computational toxicology, and\nformulation & delivery system innovation.\n\nAt the congress, Yatsen Group's R&D Director, Yi Deng, delivered a podium\npresentation on a novel microbiology testing methodology that minimizes\npreservative interference and reduces false negatives, establishing a quality\nassurance standard more reflective of real-world production across cosmetic\nformats.\n\n\nAdditionally, Yatsen's major brands —  DR.WU, Galénic, Eve Lom and Perfect\nDiary,  — presented technological applications spanning gentle skincare,\nanti-aging, eye-area care, clinical skin research and color cosmetics\ninnovation.\n\nSustained R&D Commitment\n\nYatsen's R&D network spans an advanced manufacturing hub, three global R&D\ncenters, six joint laboratories and more than 20 joint research platforms. The\nGroup has invested over RMB 770 million in R&D, with annual spending exceeding\n3% of revenue for four consecutive years. As of June 30, 2026, it filed 282\npatent applications and published 55 academic papers.\n\nAbout Yatsen Group\n\nYatsen Holding Limited (NYSE: YSG) (Yatsen Group) is a leading China-based\nbeauty group with the vision of becoming a world-class beauty innovation\npioneer. Founded in 2016, its brands — including Galénic, DR.WU (mainland\nChina business), Eve Lom, Perfect Diary and Little Ondine — cover consumer\nsegments from the mass market to prestige and clinical-grade skincare.\n\nMedia Contact: \n\nWebsite: www.yatsenglobal.com\nLinkedIn: www.linkedin.com/company/yatsen\nContact:public.affairs@yatsenglobal.com \n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/yatsen-group-expands-scientific-presence-at-prestigious-ifscc-cosmetics-congress-with-record-20-research-presentations-302909564.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2013986/20261014225821EDT_image_1.jpg?id=OA3020902\nhttps://mmx.prnewswire.com/media/MS2013984/20261014225821EDT_image_2.jpg?id=OA3020901\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-15T05:47:10.682621136Z","server_sent_at_ms":1792043230682},"received_at":"2026-10-15T05:47:10.732Z","source_url":null},"analysis":{"id":"157957","press_release_id":"169731","analysis_json":{"industry":{"label":"Personal Care Products","sector":"Consumer Staples"},"redFlags":[],"eventType":"operations_update","narrative":"Yatsen Group presented a record 20 research submissions at the 36th IFSCC Congress in Perth, nearly double its 2025 total, selected from more than 1,200 global submissions.\n\nThe company says its R&D network includes three global R&D centers, six joint laboratories, over RMB 770 million in cumulative R&D investment, 282 patent applications and 55 published academic papers as of June 30, 2026.\n\nThe release is promotional in nature with no financial results or strategic changes; it modestly reinforces Yatsen's science-driven branding in China's cosmetics sector.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Record IFSCC presence reinforces Yatsen's R&D credibility, but no financial impact."},"keyFigures":{"customDimensions":{"rd_investment":"RMB 770 million cumulative","rd_pct_revenue":"annual R&D spending exceeding 3% of revenue for four consecutive years","academic_papers":55,"submissions_pool":"more than 1,200 submissions","patent_applications":282,"research_presentations":20}},"quotedText":"Achieving a record 20 accepted contributions across our core brands reflects the collaborative strength of our global R&D ecosystem.","namedEntities":{"people":[{"name":"Jing Cheng","role":"Chief Scientific Officer"},{"name":"Yi Deng","role":"R&D Director"}],"products":["DR.WU","Galénic","Eve Lom","Perfect Diary","Little Ondine"],"companies":[{"name":"Yatsen Holding Limited","ticker":"YSG","relationship":"filer"}],"dollarAmounts":[{"amount":"RMB 770 million","context":"cumulative R&D investment"}]},"materialImpact":{"score":1,"reasoning":"Promotional R&D/branding release about conference presentations; no revenue, guidance, or strategic transaction. Mildly supportive of the innovation narrative only."},"tickerRelevance":{"others":[],"primary":"YSG"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap ADR","eventGravity":"promotional R&D update","issuerAuthored":true,"financialContent":false}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Yatsen Group presented a record 20 research submissions at the 36th IFSCC Congress in Perth, nearly double its 2025 total, selected from more than 1,200 global submissions.\n\nThe company says its R&D network includes three global R&D centers, six joint laboratories, over RMB 770 million in cumulative R&D investment, 282 patent applications and 55 published academic papers as of June 30, 2026.\n\nThe release is promotional in nature with no financial results or strategic changes; it modestly reinforces Yatsen's science-driven branding in China's cosmetics sector.","key_figures":{"customDimensions":{"rd_investment":"RMB 770 million cumulative","rd_pct_revenue":"annual R&D spending exceeding 3% of revenue for four consecutive years","academic_papers":55,"submissions_pool":"more than 1,200 submissions","patent_applications":282,"research_presentations":20}},"named_entities":{"people":[{"name":"Jing Cheng","role":"Chief Scientific Officer"},{"name":"Yi Deng","role":"R&D Director"}],"products":["DR.WU","Galénic","Eve Lom","Perfect Diary","Little Ondine"],"companies":[{"name":"Yatsen Holding Limited","ticker":"YSG","relationship":"filer"}],"dollarAmounts":[{"amount":"RMB 770 million","context":"cumulative R&D investment"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-15T05:47:15.779Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap ADR","eventGravity":"promotional R&D update","issuerAuthored":true,"financialContent":false}},"durationMs":5039,"modelName":"glm-5.3-flashx"}}